Appsilon and Roche Build on Their Collaboration to Support teal’s Continued Development
Following teal’s recent migration to pharmaverse, Appsilon and Roche are building on their existing collaboration to support the framework’s continued development. Appsilon will continue contributing developer expertise and will be formally recognized as a core contributor and copyright holder alongside Roche.
teal helps developers build Shiny applications for exploring clinical trial data. Its modular approach brings together data, filters, and analysis modules in interactive applications.
For Appsilon, this recognition formalizes its existing role in the project and its continued work alongside Roche and the wider community.
Building on Our Contributions to teal
Appsilon has been working with Roche as a core contributor to teal’s development. This work includes co-implementing the new teal design, teal.reporter, and teal.picks, contributing to improvements in the framework’s quality and capabilities.
Appsilon will continue co-leading teal’s maintenance and development alongside Roche, with input and contributions from the wider community. The collaboration remains open to other companies and individual contributors who want to help shape the framework’s direction.
It’s been rewarding to see teal grow and support colleagues across the biotech and pharmaceutical community. Moving to pharmaverse opens a new chapter in that journey, and I’m excited to build on our longstanding collaboration with Appsilon through a shared commitment to open-source development. Together with the wider community, we look forward to shaping teal’s future and expanding what it can help users achieve.
— Dony Unardi, Roche (teal Product Owner and NEST Chief Engineer)
With teal, clinical teams don’t start from a blank page. Its modular design lets us assemble interactive exploration apps from proven, ready-made building blocks and focus our effort on what’s unique to each study and customize it accordingly. As co-copyright holders, we’ll keep investing in that foundation, so every team building on teal can move from data to insight faster.
— Wojciech Gajewski, Head of Delivery, Appsilon
What Changes for Users and Contributors?
The teal framework packages are now hosted in the pharmaverse GitHub organization, as described in the earlier migration announcement.
Users of existing released versions do not need to change their R code as a result of the move. For development versions installed directly from GitHub, we recommend updating package references to their new pharmaverse locations.
Users and contributors can continue reporting issues, proposing features, and submitting pull requests in the package repositories. Community feedback and contributions remain an important part of teal’s development.
We are excited to welcome Appsilon as a partner for teal. Open source ecosystems like pharmaverse thrive when dedicated communities and forward-thinking organizations step up together as one - enabling powerful frameworks like teal to flourish and drive real impact. We hope this move to the pharmaverse org also encourages further contribution from across the industry, so this continues to prosper.
— Ross Farrugia, Roche (pharmaverse co-founder)
What’s Next for teal?
Future development will focus on making teal easier to contribute to and strengthening its use in validated environments.
Work includes expanding guidance for AI-assisted development across the core and module packages, alongside improvements to testing and dependency management. Roche and Appsilon will continue working with the wider community to shape priorities and guide the framework’s development.
Continuing the Community’s Work
teal was created at Roche and has grown through the work of developers and users contributing code, modules, documentation, bug reports, and feedback. Appsilon has been part of that work and will continue supporting the framework alongside Roche and other contributors.
We thank Dony Unardi, Dawid Kałędkowski, Pawel Rucki, Aleksander Chlebowski, Andre Verissimo, Kartikeya Kirar, Vedha Viyash, Marcin Kosinski, Adrian Waddell, Nikolas Burkoff, Mahmoud Hallal, Maciej Nasinski, Konrad Pagacz, Junlue Zhao, Tadeusz Lewandowski, Lluis Revilla, and everyone else who has helped develop and maintain teal.
We look forward to continuing to work with you and welcoming new contributors.
If you use teal, your feedback helps shape it. Report an issue, suggest an improvement, contribute a module, or join the conversation in the Pharmaverse Slack’s #teal channel.
Explore the repository · Read the documentation · Read the contribution guide
